Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ARDS Due to COVID-19”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Not applicableNo Longer AvailableNCT04366830
What this trial is testing

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection

Who this might be right for
Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19
Mesoblast International Sàrl
Testing effectiveness (Phase 2)WithdrawnNCT05018975
What this trial is testing

Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeCytokine Release Syndrome
Loma Linda University
Not applicableStudy completedNCT05650957
What this trial is testing

PRactice of VENTilation in Patients With ARDS Due to COVID-19 vs Pneumonia

Who this might be right for
Acute Respiratory Distress SyndromeCOVID-19Pneumonia+1 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 7,145
Post-approval studies (Phase 4)Study completedNCT04326920
What this trial is testing

Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)

Who this might be right for
COVID-19
University Hospital, Ghent 87
Early research (Phase 1)WithdrawnNCT04490486
What this trial is testing

Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19

Who this might be right for
COVID-19Acute Respiratory Distress SyndromeCorona Virus Infection
Joshua M Hare
Not applicableStudy completedNCT05012267
What this trial is testing

Duration of Prone Position in the Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19).

Who this might be right for
Ards
Ignacio Saez de la Fuente 61
Not applicableEnded earlyNCT04397172
What this trial is testing

Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19

Who this might be right for
COVIDCorona Virus InfectionSars-CoV2
Insel Gruppe AG, University Hospital Bern 48
Testing effectiveness (Phase 2)Ended earlyNCT04390152
What this trial is testing

Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19

Who this might be right for
Acute Respiratory Distress Syndrome
BioXcellerator 6
Early research (Phase 1)Ended earlyNCT05135624
What this trial is testing

SP16 as a Therapeutic for COVID-19 Induced ARDS

Who this might be right for
SARS CoV 2 InfectionPneumonia
Serpin Pharma, LLC 2
Not applicableUnknownNCT04568018
What this trial is testing

Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19

Who this might be right for
ARDS Due to COVID-19
Biosurf LLC. 120
Not applicableLooking for participantsNCT05562505
What this trial is testing

Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure

Who this might be right for
Mechanical Ventilation ComplicationHypoxemiaAcute Respiratory Distress Syndrome Due to COVID-19+3 more
Australian and New Zealand Intensive Care Research Centre 140
Large-scale testing (Phase 3)UnknownNCT04367077
What this trial is testing

MultiStem Administration for COVID-19 Induced ARDS (MACoVIA)

Who this might be right for
ARDS
Healios K.K. 400
Not applicableStudy completedNCT05115526
What this trial is testing

PEEP Setting in COVID19-related ARDS

Who this might be right for
ARDS Due to Severe Acute Respiratory Syndrome Coronavirus 2
Central Hospital, Nancy, France 17
Not applicableStudy completedNCT04894214
What this trial is testing

Flow-controlled Ventilation (FCV) in Moderate Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeRespiration, Artificial
University Hospital, Antwerp 11
Testing effectiveness (Phase 2)UnknownNCT04397497
What this trial is testing

Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)

Who this might be right for
Covid-19Acute Respiratory FailureARDS, Human+2 more
Ospedale San Raffaele 50
Testing effectiveness (Phase 2)Study completedNCT04356833
What this trial is testing

Nebulised Rt-PA for ARDS Due to COVID-19

Who this might be right for
COVID
University College, London 35
Not applicableAvailableNCT04657406
What this trial is testing

Expanded Access to Zofin for Patients With COVID-19

Who this might be right for
Covid19Corona Virus InfectionSARS (Severe Acute Respiratory Syndrome)+1 more
ZEO ScientifiX, Inc.
Early research (Phase 1)Study completedNCT04537351
What this trial is testing

The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause

Who this might be right for
Covid19Acute Respiratory Distress Syndrome
Cynata Therapeutics Limited 14
Testing effectiveness (Phase 2)UnknownNCT04780685
What this trial is testing

A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19

Who this might be right for
Covid19
Stemedica Cell Technologies, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT04378920
What this trial is testing

Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes

Who this might be right for
COVID19, Sepsis or Other CausesAcute Respiratory Distress Syndrome
Institut de cancérologie Strasbourg Europe 37
Load More Results